Please use this identifier to cite or link to this item: https://hdl.handle.net/10137/12146
Title: Clinical Presentations and Outcomes of Children in Canada With Recurrent Invasive Pneumococcal Disease From the IMPACT Surveillance Network.
Authors: Murad, Yousif
Hung, Te-Yu
Sadarangani, Manish
Morris, Shaun K
Le Saux, Nicole
Vanderkooi, Otto G
Kellner, James D
Tyrrell, Gregory J
Martin, Irene
Demczuk, Walter
Halperin, Scott A
Bettinger, Julie A
Bridger, N
Foo, Cheryl
Halperin, S A
Top, K A
Thibeault, R
Moore, D
Papenburg, J
Lebel, M
Le Saux, N
Morris, S
Embree, J
Tan, B
McConnell, Athena
Jadavji, T
Constantinescu, C
Vaudry, W
Scheifele, D
Sadarangani, M
Bettinger, J
Sauvé, L
Citation: Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc.
Pediatr Infect Dis J. 2022 Apr 1;41(4):e166-e171. doi: 10.1097/INF.0000000000003454.
Abstract: BACKGROUND: Invasive pneumococcal disease due to Streptococcus pneumoniae can cause mortality and severe morbidity due to sepsis, meningitis and pneumonia, particularly in young children and the elderly. Recurrent invasive pneumococcal disease is rare yet serious sequelae of invasive pneumococcal disease that is associated with the immunocompromised and leads to a high mortality rate. METHOD: This retrospective study reviewed recurrent invasive pneumococcal disease cases from the Canadian Immunization Monitoring Program, ACTive (IMPACT) between 1991 and 2019, an active network for surveillance of vaccine-preventable diseases and adverse events following immunization for children ages 0-16 years. Data were collected from 12 pediatric tertiary care hospitals across all 3 eras of public pneumococcal conjugate vaccine implementation in Canada. RESULTS: The survival rate within our cohort of 180 recurrent invasive pneumococcal disease cases was 98.3%. A decrease of 26.4% in recurrent invasive pneumococcal disease due to vaccine serotypes was observed with pneumococcal vaccine introduction. There was also a 69.0% increase in the rate of vaccination in children with preexisting medical conditions compared with their healthy peers. CONCLUSION: The decrease in recurrent invasive pneumococcal disease due to vaccine-covered serotypes has been offset by an increase of non-vaccine serotypes in this sample of Canadian children.
Click to open Pubmed Article: https://www.ezpdhcs.nt.gov.au/login?url=https://www.ncbi.nlm.nih.gov/pubmed/35093996
Journal title: The Pediatric infectious disease journal
Volume: 41
Pages: e166-e171
Publication Date: 2022-04-01
Type: Journal Article
URI: https://hdl.handle.net/10137/12146
DOI: 10.1097/INF.0000000000003454
Appears in Collections:(a) NT Health Research Collection

Files in This Item:
There are no files associated with this item.


Items in ePublications are protected by copyright, with all rights reserved, unless otherwise indicated.

Google Media

Google ScholarTM

Who's citing

Pubmed

PubMed References

Who's citing